Apo-Amitriptyline recall in Canada: may exceed NNORT limit
In plain language
This recall involves Apo-Amitriptyline tablets sold in Canada. It's being recalled because certain lots may exceed the acceptable limit for an impurity called NNORT. Consult your healthcare provider before stopping use and follow the instructions in the official notice.
What to do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use or for any health concerns.
- Contact the recalling firm if you have questions.
- Report any health product related side effects to Health Canada.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Apo-Amitriptyline 10 mg Tablet
Lot: RN6384, RR0265, RR0266, RV1644, RV1645, RW8597, RW8598, TA6008, TA6009, TF8585, TF8586, TF8587, TF8588, TF8589, TW2842, TW2843
Apo-Amitriptyline 25 mg Tablet
Lot: RM0519, RM8130, RR0780, RR0781, RV1656, RV1657, RW8691, TA6061, TA6062, TF8602, TF8603
Why this matters
Product safety issue due to impurity
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: RM0519, RM8130, RR0780, RR0781, RV1656, RV1657, RW8691, TA6061, TA6062, TF8602, TF8603, RN6384, RR0265, RR0266, RV1644, RV1645, RW8597, RW8598, TA6008, TA6009, TF8585, TF8586, TF8587, TF8588, TF8589, TW2842, TW2843
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Product safety issue due to impurity
What should consumers do?
Verify if your product is affected. Consult your healthcare provider prior to discontinuing use or for any health concerns. Contact the recalling firm if you have questions. Report any health product related side effects to Health Canada.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Product safety issue due to impurity
When was this product recalled?
This product was recalled on October 17, 2024.
Is the Apo brand affected by this recall?
Yes, Apo products are affected by this recall. This recall involves Apo-Amitriptyline tablets sold in Canada. It's being recalled because certain lots may exceed the acceptable limit for an impurity called NNORT. Consult your healthcare provider before stopping use and follow the instructions in the official notice.